Everence Capital Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,100
Closed -$207K 870
2025
Q4
$207K Hold
4,100
0.01% 738
2025
Q3
$205K Buy
+4,100
New +$188K 0.01% 764
2022
Q2
Sell
-10,630
Closed -$562K 755
2022
Q1
$562K Buy
10,630
+4,930
+86% +$259K 0.04% 351
2021
Q4
$293K Buy
5,700
+2,430
+74% +$143K 0.02% 593
2021
Q3
$218K Sell
3,270
-1,630
-33% -$127K 0.02% 670
2021
Q2
$450K Hold
4,900
0.04% 425
2021
Q1
$597K Hold
4,900
0.05% 306
2020
Q4
$752K Hold
4,900
0.07% 219
2020
Q3
$635K Hold
4,900
0.07% 229
2020
Q2
$619K Hold
4,900
0.07% 229
2020
Q1
$373K Hold
4,900
0.05% 320
2019
Q4
$498K Hold
4,900
0.07% 287
2019
Q3
$500K Hold
4,900
0.08% 262
2019
Q2
$568K Buy
4,900
+1,000
+26% +$108K 0.09% 226
2019
Q1
$410K Buy
3,900
+770
+25% +$86.4K 0.07% 306
2018
Q4
$353K Buy
3,130
+1,410
+82% +$174K 0.08% 255
2018
Q3
$278K Hold
1,720
0.06% 334
2018
Q2
$205K Hold
1,720
0.04% 400
2018
Q1
$202K Buy
+1,720
New +$194K 0.04% 394

Other funds holding PRLB

Everence Capital Management's PRLB Position: Q1 2026 in Review

Everence Capital Management sold out of Protolabs (PRLB) in Q1 2026, closing a stake of 4,100 shares — an estimated $207K sold.

Everence Capital Management first reported a position in PRLB in Q1 2018 and held it in 19 quarters. The position peaked at $752K in Q4 2020. 262 funds tracked by Wall St. Rank hold PRLB as of Q1 2026.

  • Everence Capital Management reported no remaining Protolabs position as of Q1 2026 after selling out during the quarter.
  • Everence Capital Management sold 4,100 Protolabs shares in Q1 2026, an estimated $207K.
  • Everence Capital Management first reported a position in Protolabs in Q1 2018 and held it in 19 quarters.
  • Everence Capital Management's Protolabs position peaked at $752K in Q4 2020.
  • 262 funds tracked by Wall St. Rank held Protolabs as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.